LifeStance Health Long Term Debt 2020-2024 | LFST
LifeStance Health long term debt from 2020 to 2024. Long term debt can be defined as the sum of all long term debt fields.
| LifeStance Health Annual Long Term Debt (Millions of US $) |
|
|---|---|
| 2023 | $280 |
| 2022 | $225 |
| 2021 | $157 |
| 2020 | $363 |
| 2019 | $79 |
| LifeStance Health Quarterly Long Term Debt (Millions of US $) |
|
|---|---|
| 2024-09-30 | $279 |
| 2024-06-30 | $279 |
| 2024-03-31 | $280 |
| 2023-12-31 | $280 |
| 2023-09-30 | $248 |
| 2023-06-30 | $249 |
| 2023-03-31 | $225 |
| 2022-12-31 | $225 |
| 2022-09-30 | $212 |
| 2022-06-30 | $203 |
| 2022-03-31 | $177 |
| 2021-12-31 | $157 |
| 2021-09-30 | $157 |
| 2021-06-30 | $157 |
| 2021-03-31 | $387 |
| 2020-12-31 | $363 |
| 2020-09-30 | |
| 2020-06-30 | |
| 2020-03-31 | |
| 2019-12-31 | $79 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $2.904B | $1.056B |
| LifeStance Health Group Inc. is provider of virtual and in-person outpatient mental health care for children, adolescents and adults of mental health conditions. LifeStance Health Group Inc. is based in SCOTTSDALE, Ariz. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $21.804B | 0.00 |
| Quest Diagnostics (DGX) | United States | $19.317B | 19.51 |
| DaVita (DVA) | United States | $11.363B | 14.49 |
| Encompass Health (EHC) | United States | $9.962B | 22.32 |
| Chemed (CHE) | United States | $8.236B | 25.31 |
| Elanco Animal Health (ELAN) | United States | $5.492B | 13.07 |
| Option Care Health (OPCH) | United States | $5.459B | 25.87 |
| RadNet (RDNT) | United States | $4.453B | 98.62 |
| Amedisys (AMED) | United States | $2.998B | 21.34 |
| Addus HomeCare (ADUS) | United States | $1.974B | 22.91 |
| Astrana Health (ASTH) | United States | $1.946B | 26.61 |
| U.S Physical Therapy (USPH) | United States | $1.298B | 34.13 |
| Pennant (PNTG) | United States | $0.864B | 34.93 |
| Aveanna Healthcare Holdings (AVAH) | United States | $0.799B | 0.00 |
| Atai Life Sciences (ATAI) | Germany | $0.305B | 0.00 |
| Bioqual (BIOQ) | United States | $0.054B | 0.00 |
| Daxor (DXR) | United States | $0.036B | 0.00 |
| Ontrak (OTRK) | United States | $0.007B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.004B | 0.00 |
| IMAC Holdings (BACK) | United States | $0.001B | 0.00 |
| Psychemedics (PMD) | United States | $0.000B | 0.00 |